We detected 2-3-fold enhanced 89Zr-hCD4-Mb uptake in the spleens and lymph nodes of PyMT tumor-bearing hCD4-KI mice compared with WT mice (Figure 3B, C; Figure S3A-B, S4B). This evidence concerns the gene MB and neoplasm.